233 related articles for article (PubMed ID: 7438723)
1. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
Amato M; Bigioli F; Beconi D; Martinelli F; Lapini V; Salvadori M
Clin Ter; 1980 Jul; 94(1):57-65. PubMed ID: 7438723
[No Abstract] [Full Text] [Related]
2. [Treatment of chronic uremic anemia in patients undergoing periodic extracorporeal dialysis with large doses of anabolic androgens].
Pentangelo C; Mazza L; Scoppa F
Rass Int Clin Ter; 1971 Oct; 51(20):1268-76. PubMed ID: 5137470
[No Abstract] [Full Text] [Related]
3. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
[No Abstract] [Full Text] [Related]
4. [Testosterone in the therapy of anemia in the uremic patient treated by periodic hemodialysis].
Brancaccio D; Pincella G; Graziani G; Redaelli B
Minerva Nefrol; 1972; 19(4):269-73. PubMed ID: 4681104
[No Abstract] [Full Text] [Related]
5. [Iron poisoning as a risk in the treatment of nephrogenic anemia].
Hansen BL; Pedersen FB
Ugeskr Laeger; 1985 Aug; 147(35):2747-9. PubMed ID: 4071711
[No Abstract] [Full Text] [Related]
6. [Anemia in patients treated with periodic hemodialysis. Therapeutic criteria and long-term results].
Bucciante G; Frizzi V; Bernardi AM; Amadori G
Minerva Urol; 1978; 30(2):85-95. PubMed ID: 703731
[No Abstract] [Full Text] [Related]
7. [Gynecomastia in the uremic patient undergoing periodic hemodialytic treatment].
Sodi A; Rizzo M; Somigli M
Minerva Nefrol; 1969; 16(6):420-4. PubMed ID: 5403806
[No Abstract] [Full Text] [Related]
8. Think of oxalate when using ascorbate supplementation to optimize iron therapy in dialysis patients.
Canavese C; Marangella M; Stratta P
Nephrol Dial Transplant; 2008 Apr; 23(4):1463-4; author reply 1464. PubMed ID: 18029374
[No Abstract] [Full Text] [Related]
9. [Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment].
Bergesio F; Ciuti R; Manfredi M; Frizzi V; Zerboni R
Minerva Nefrol; 1983; 30(3):165-73. PubMed ID: 6646491
[No Abstract] [Full Text] [Related]
10. [Study of plasma renin activity in uremic patients undergoing periodic hemodialytic treatment].
Pigliucci GM; Suraci V; Alcini E
Chir Patol Sper; 1974 Apr; 22(2):89-97. PubMed ID: 4434788
[No Abstract] [Full Text] [Related]
11. [The visual apparatus in the chronic uremic patient during periodic hemodialytic treatment. II. Changes in ocular refraction during hemodialysis].
Ambrosio A; Sorice PS; Tufano L; Tonna G; Esposito E
Rass Int Clin Ter; 1971 Jul; 51(13):789-95. PubMed ID: 5568452
[No Abstract] [Full Text] [Related]
12. [Changes in prolactin in uremic patients under periodic hemodialytic treatment].
Gasparotto ML; Serafini E; Naso A; Bertoli M; Rebeschini M; Di Landro D; Ruffatti A; Romagnoli GF; Mastrogiacomo I
Minerva Nefrol; 1982; 29(2):101-4. PubMed ID: 7133538
[No Abstract] [Full Text] [Related]
13. [Anemia and hormone therapy for patients on intermittent chronic hemodialysis].
Matsuoka H; Tamura T
Horumon To Rinsho; 1974 Aug; 22(8):951-4. PubMed ID: 4476258
[No Abstract] [Full Text] [Related]
14. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
[TBL] [Abstract][Full Text] [Related]
15. [The influence of twice-weekly hemodialytic treatment on the hypertensive syndrome in chronic uremic patients].
Cioni L; Biagini M; Gloria E; Pentimone F
Minerva Nefrol; 1966; 13(4):112-5. PubMed ID: 5995530
[No Abstract] [Full Text] [Related]
16. Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment.
Cannella G; Guerra UP; Sandrini M; Gaggiotti M; Traverso GB; Rolla D; Marsano L; Mulas D
Clin Nephrol; 1993 Sep; 40(3):164-7. PubMed ID: 8403572
[TBL] [Abstract][Full Text] [Related]
17. [Human pharmacological study of quinbolone. Clinical and laboratory investigations of the effects of anabolic treatment in aged women].
Mezzena R; Foresti M; Trisotto M; Bruni G
G Gerontol; 1972 Apr; 20(4):361-78. PubMed ID: 5042390
[No Abstract] [Full Text] [Related]
18. Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klepacka J; Klin M; Lao M
Contrib Nephrol; 1989; 76():257-70; discussion 270-2. PubMed ID: 2582782
[No Abstract] [Full Text] [Related]
19. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
[No Abstract] [Full Text] [Related]
20. [Cimetidine in the therapy of secondary hyperparathyroidism in uremia with hemodialytic treatment].
Antonucci F; Gropuzzo M; Messa P; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Messa M
Minerva Nefrol; 1983; 30(3):133-9. PubMed ID: 6646487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
